◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

Processa Pharmaceuticals, Inc.

CIK: 1533743 SIC: 2834
-
Revenue
$-13.56M
Net Income
-
Gross Margin
-
Op. Margin
$-19.12M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 5 of 12 annual reports available (2013 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Operating Income $-13.99M $-13.99M $-12.05M $-11.46M $-27.53M $-12.13M
Interest Expense $9.37K $5.61K $1.20K - - $362.00
Interest Income - $109.49K $201.09K $335.54K $101.20K $11.99K
Income Before Tax - $-13.56M $-11.85M $-11.12M $-27.42M $-11.96M
Income Tax Expense - - - - - $-530.61K
Net Income $-13.56M $-13.56M $-11.85M $-11.12M $-27.42M $-11.43M
Basic EPS nan -10.36 -3.87 -8.48 -1.70 -0.75
Diluted EPS nan -10.36 -3.87 -8.48 -34.05 nan
Basic Shares Outstanding - 1.3M 122K 1.3M 16.1M 15.3M
Diluted Shares Outstanding - 1.3M 122K 1.3M 805K -
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Cash & Cash Equivalents $5.54M $1.19M $4.71M $6.50M $16.50M
Other Current Assets $133.92K $687.83K $926.30K $1.88M $1.76M
Total Current Assets $5.67M $1.88M $5.63M $8.39M $18.33M
Property Plant & Equipment $3.81K $5.02K $2.55K - -
Intangible Assets - - - - $8.06M
Other Non-current Assets - - $5.54K $5.54K $8.14M
Total Assets $7.81M $3.23M $5.79M $8.62M $26.46M
Accounts Payable $1.06M $880.88K $311.62K $327.55K $218.91K
Accrued Liabilities $1.18M $578.73K $146.27K $403.06K $279.26K
Other Current Liabilities - - $39.00 $51.00 -
Total Current Liabilities $2.24M $1.53M $730.58K $998.56K $971.02K
Total Liabilities $2.24M $1.53M $797.48K $1.15M $978.40K
Common Stock $257.00 $15.00 $129.00 $1.61K $1.57K
Retained Earnings $-100.78M $-87.22M $-75.37M $-64.25M $-36.82M
Treasury Stock $300.00K $300.00K $300.00K $300.00K -
Total Stockholders Equity $5.58M $1.70M $4.99M $7.47M $25.49M
Total Liabilities & Equity $7.81M $3.23M $5.79M $8.62M $26.46M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
Net Income $-13.56M $-13.56M $-11.85M $-11.12M $-27.42M $-11.43M
Stock-based Compensation $1.52M $857.55K $629.51K $1.06M $8.83M $3.41M
Deferred Income Tax - - - - - $-530.61K
Change in Payables $-247.53K $175.92K $569.26K $-15.93K $108.64K $-101.79K
Operating Cash Flow $-19.12M $-11.39M $-11.25M $-8.06M $-9.61M $-8.72M
Capital Expenditure - - $3.24K $2.78K - -
Investing Cash Flow - $-850.00K $-3.24K $-2.78K - -
Stock Issued - $16.60M $7.76M $6.32M - $10.05M
Stock Repurchased - - - - $300.00K -
Financing Cash Flow $31.76M $16.58M $7.73M $6.27M $-388.84K $9.80M
Net Change in Cash $11.80M $4.35M $-3.51M $-1.80M $-9.99M $1.08M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Operating Income $-3.49M - $-10.29M -
Interest Expense - - $5.59K -
Net Income $-3.44M $-3.01M $-10.20M -
Basic EPS -0.07 - -0.41 -
Diluted EPS -0.07 - -0.41 -
Basic Shares Outstanding $47.53M - $24.84M -
Diluted Shares Outstanding $47.53M - $24.84M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $6.31M $1.19M
Other Current Assets $278.34K $687.83K
Total Current Assets $6.59M $1.88M
Property Plant & Equipment $4.11K $5.02K
Total Assets $7.58M $3.23M
Accounts Payable $727.17K $880.88K
Accrued Liabilities $1.02M $578.73K
Total Current Liabilities $1.75M $1.53M
Total Liabilities $1.75M $1.53M
Common Stock $5.29K $371.00
Retained Earnings $-97.42M $-87.22M
Treasury Stock $300.00K $300.00K
Total Stockholders Equity $5.83M $1.70M
Total Liabilities & Equity $7.58M $3.23M
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $-3.44M $-3.01M $-10.20M -
Stock-based Compensation - - $734.01K -
Change in Payables - - $-153.71K -
Operating Cash Flow - - $-8.48M -
Investing Cash Flow - - - -
Financing Cash Flow - - $13.60M -
Net Change in Cash - - $5.12M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...